MALVERN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today released the findings of its research of clinical stakeholders regarding their ...

MALVERN, PA — YPrime has introduced groundbreaking updates to its electronic clinical outcome assessment (eCOA) platform, announcing a new AI Migration Tool designed to transform the way ...

MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today unveiled significant enhancement ...

MALVERN, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today unveiled significant enhancements to its electronic clinical outcome assessment ...

MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today announced the availability of a new report, Insights into CNS Clinical Trials, which ...

MALVERN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today released the findings of its research of clinical stakeholders regarding their ...

Media Contact Terry Rehm Head of Thought Leadership and Public Relations, YPrime trehm@yprime.com 862-288-0329 References 1 - The Lancet, March 14, 2024.

MALVERN, Pa., Jan. 14, 2025 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today announced that Dr. Karl McEvoy, Vice President, eCOA and Patient Technologies, has ...

YPrime's reimagined automated DCF solution, part of its industry-leading 7.x eCOA platform, tackles this challenge head-on by automating data changes, significantly reducing the need for manual ...

Survey explores how eCOA enhances patient experience and reduces risk and uncertainty News provided by Y-Prime, LLC Apr 03, 2024, 8:00 AM ET ...

Recent innovations from YPrime include the launch of eCOA 7.0, a no-code, configurable platform that accelerates study launches by 30%, supporting both complex and simple trials.